溶解性 | DMSO |
存贮条件 | 储存温度-20°C |
生化机理 | Lersivirine (UK-453061) is a next-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) under development for the treatment of HIV-1 infection. Lersivirine prevents HIV from entering the nucleus of healthy CD4 cells. This prevents the cells from producing new virus and decreases the amount of virus in the body. Lersivirine, a weak inducer of the cytochrome P450 (CYP) enzyme CYP3A4, is metabolized by CYP3A4 and UDP glucuronosyltransferase 2B7 (UGT2B7). |
别名 | ; |
Lersivirine,抑制剂
Lersivirine (订货以英文为准)
编号:L125187
CAS号:473921-12-9
分子式:C17H18N4O2
分子量:310.35
产品名称 | Lersivirine |
中文名称 | Lersivirine,抑制剂 |
CAS号 | 473921-12-9 |
分子式(M.F.) | C17H18N4O2 |
分子量(M.W.) | 310.35 |
储存条件 | -20°C储存 |
WGK德国 | 3 |
搜索质检报告(COA)
搜索MSDS
相关产品